Hillcrest Asset Management’s Select Medical SEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
$13.4M Sell
846,334
-123,536
-13% -$2.11M 2.04% 13
2021
Q3
$18.9M Sell
969,870
-40,238
-4% -$799K 2.7% 2
2021
Q2
$23M Sell
1,010,108
-188,736
-16% -$3.92M 3.11% 1
2021
Q1
$22M Sell
1,198,844
-6,311
-0.5% -$103K 2.57% 1
2020
Q4
$18M Sell
1,205,155
-3,173
-0.3% -$41.4K 2.44% 1
2020
Q3
$13.6M Sell
1,208,328
-32,852
-3% -$323K 2.4% 9
2020
Q2
$9.85M Buy
+1,241,180
New +$10.3M 1.8% 26

Other funds holding SEM

Hillcrest Asset Management's SEM Position: Q4 2021 in Review

Hillcrest Asset Management reduced its Select Medical (SEM) stake by 13% in Q4 2021, selling an estimated $2.11M and leaving 846,334 shares worth $13.4M. The position accounts for 2.04% of the portfolio, ranked #13.

Hillcrest Asset Management first reported a position in SEM in Q2 2020 and has held it in 7 quarters since. The position peaked at $23M in Q2 2021. 244 funds tracked by Wall St. Rank hold SEM as of Q4 2021.

  • Hillcrest Asset Management held 846,334 shares of Select Medical worth $13.4M as of Q4 2021.
  • Hillcrest Asset Management sold 123,536 Select Medical shares in Q4 2021, an estimated $2.11M.
  • Select Medical made up 2.04% of Hillcrest Asset Management's portfolio in Q4 2021, its #13 holding.
  • Hillcrest Asset Management first reported a position in Select Medical in Q2 2020 and has held it in 7 quarters since.
  • Hillcrest Asset Management's Select Medical position peaked at $23M in Q2 2021.
  • 244 funds tracked by Wall St. Rank held Select Medical as of Q4 2021.

Based on Hillcrest Asset Management's 13F filing for Q4 2021, filed 24 Feb 2022.